April 2024
1. HARRIS E
   Therapy Delivered by Nonspecialists Improved Postpartum Mental Health.
   JAMA. 2024;331:1265-1266.
   

   >> Share

   
   
2. HARRIS E
   Antidepressant Prescriptions for Female Teens Surged After Pandemic.
   JAMA. 2024;331:1266.
   

   >> Share

   
   
3. NITZAN I, Philips R, White RD
   Screening Recommendations and Treatments for Postpartum Depression.
   JAMA. 2024;331:1153-1154.
   

   >> Share

   
   
4. MOORE SIMAS TA, Whelan A, Byatt N
   Screening Recommendations and Treatments for Postpartum Depression-Reply.
   JAMA. 2024;331:1154.
   

   >> Share

   
   March 2024
5. VOELKER R
   What Is Perinatal Depression?
   JAMA. 2024 Mar 14. doi: 10.1001/jama.2024.0434.
   

   >> Share

   
   February 2024
6. HARRIS E
   Meta-Analysis: Exercise as Effective as Therapy for Treating Depression.
   JAMA. 2024 Feb 28. doi: 10.1001/jama.2024.1121.
   

   >> Share

   
   January 2024
7. HARRIS E
   Machine Learning Algorithms Failed to Find Depression Biomarker.
   JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28339.
   

   >> Share

   
   
8. HARRIS E
   Perinatal Depression Tied to Higher Long-Term Risk of Death.
   JAMA. 2024 Jan 31. doi: 10.1001/jama.2023.28341.
   

   >> Share

   
   
9. THORNBURG B, Kennedy-Hendricks A, Rosen JD, Eisenberg MD, et al
   Anxiety and Depression Symptoms After the Dobbs Abortion Decision.
   JAMA. 2024;331:294-301.
   

   >> Share

   
   November 2023
10. MOORE SIMAS TA, Whelan A, Byatt N
    Postpartum Depression-New Screening Recommendations and Treatments.
    JAMA. 2023 Nov 27. doi: 10.1001/jama.2023.21311.
    

    >> Share

    
    October 2023
11. HARRIS E
    LSD Use Increasing More Among People With Depression.
    JAMA. 2023 Oct 25. doi: 10.1001/jama.2023.20630.
    

    >> Share

    
    
12. HARRIS E
    Esketamine More Effective Than Quetiapine for Hard-to-Treat Depression.
    JAMA. 2023 Oct 18. doi: 10.1001/jama.2023.19797.
    

    >> Share

    
    September 2023
13. AL-KAISEY AM, Parameswaran R, Bryant C, Anderson RD, et al
    Atrial Fibrillation Catheter Ablation vs Medical Therapy and Psychological Distress: A Randomized Clinical Trial.
    JAMA. 2023;330:925-933.
    

    >> Share

    
    
14. RAISON CL, Sanacora G, Woolley J, Heinzerling K, et al
    Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.
    JAMA. 2023;330:843-853.
    

    >> Share

    
    August 2023
15. RUBIN R
    A Fast-Acting Pill Received Approval for Postpartum Depression-Is It a Game Changer?
    JAMA. 2023 Aug 23. doi: 10.1001/jama.2023.16499.
    

    >> Share

    
    July 2023
16. HARRIS E
    Depression After Head Injury Might Be Separate Disorder.
    JAMA. 2023 Jul 12. doi: 10.1001/jama.2023.12543.
    

    >> Share

    
    June 2023
17. JIN J
    Screening for Depression and Suicide Risk in Adults.
    JAMA. 2023;329:2102.
    

    >> Share

    
    
18. O'CONNOR EA, Perdue LA, Coppola EL, Henninger ML, et al
    Depression and Suicide Risk Screening: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2023;329:2068-2085.
    

    >> Share

    
    
19. BARRY MJ, Nicholson WK, Silverstein M, Chelmow D, et al
    Screening for Depression and Suicide Risk in Adults: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2023;329:2057-2067.
    

    >> Share

    
    May 2023
20. HARRIS E
    Ketamine Noninferior to Electroconvulsive Therapy For Depression.
    JAMA. 2023 May 31. doi: 10.1001/jama.2023.9604.
    

    >> Share

    
    March 2023
21. HARRIS E
    Combining Drugs Improved Hard-to-Treat Depression in Older Adults.
    JAMA. 2023 Mar 15. doi: 10.1001/jama.2023.3309.
    

    >> Share

    
    February 2023
22. LEICHSENRING F, Heim N, Leweke F, Spitzer C, et al
    Borderline Personality Disorder: A Review.
    JAMA. 2023;329:670-679.
    

    >> Share

    
    November 2022
23. NELSON HD, Darney BG, Ahrens K, Burgess A, et al
    Associations of Unintended Pregnancy With Maternal and Infant Health Outcomes: A Systematic Review and Meta-analysis.
    JAMA. 2022;328:1714-1729.
    

    >> Share

    
    October 2022
24. MANGIONE CM, Barry MJ, Nicholson WK, Cabana M, et al
    Screening for Depression and Suicide Risk in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2022 Oct 11. pii: 2797145. doi: 10.1001/jama.2022.16946.
    

    >> Share

    
    
25. JIN J
    Screening for Depression and Suicide Risk in Children and Adolescents.
    JAMA. 2022 Oct 11. pii: 2797147. doi: 10.1001/jama.2022.18187.
    

    >> Share

    
    
26. BUKSTEIN OG
    Screening for Adolescent Depression and Suicide Risk.
    JAMA. 2022 Oct 11. pii: 2797148. doi: 10.1001/jama.2022.15223.
    

    >> Share

    
    
27. VISWANATHAN M, Wallace IF, Cook Middleton J, Kennedy SM, et al
    Screening for Depression and Suicide Risk in Children and Adolescents: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2022 Oct 11. pii: 2797146. doi: 10.1001/jama.2022.16310.
    

    >> Share

    
    August 2022
28. GOODWIN RD, Davidson L
    Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders.
    JAMA. 2022;328:585.
    

    >> Share

    
    
29. HAN B, Tipperman D, Compton WM
    Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders-Reply.
    JAMA. 2022;328:585-586.
    

    >> Share

    
    July 2022
30. IOSIFESCU DV
    Pharmacogenomic Testing for Next-Step Antidepressant Selection: Still a Work in Progress.
    JAMA. 2022;328:146-148.
    

    >> Share

    
    
31. OSLIN DW, Lynch KG, Shih MC, Ingram EP, et al
    Effect of Pharmacogenomic Testing for Drug-Gene Interactions on Medication Selection and Remission of Symptoms in Major Depressive Disorder: The PRIME Care Randomized Clinical Trial.
    JAMA. 2022;328:151-161.
    

    >> Share

    
    June 2022
32. SLOMSKI A
    Even Low Amounts of Physical Activity Reduce Depression Risk.
    JAMA. 2022;327:2066.
    

    >> Share

    
    May 2022
33. SLOMSKI A
    Antidepressant Combinations Compared With Monotherapy.
    JAMA. 2022;327:1641.
    

    >> Share

    
    April 2022
34. HAN B, Volkow ND, Blanco C, Tipperman D, et al
    Trends in Prevalence of Cigarette Smoking Among US Adults With Major Depression or Substance Use Disorders, 2006-2019.
    JAMA. 2022;327:1566-1576.
    

    >> Share

    
    
35. CHEN MH, Liang CS, Su KP
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression.
    JAMA. 2022;327:1291-1292.
    

    >> Share

    
    
36. LIANG CS, Tseng PT, Su KP
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression.
    JAMA. 2022;327:1290-1291.
    

    >> Share

    
    
37. OKEREKE OI, Mischoulon D, Manson JE
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression-Reply.
    JAMA. 2022;327:1292.
    

    >> Share

    
    January 2022
38. NIKNAM BA, Zubizarreta JR
    Using Cardinality Matching to Design Balanced and Representative Samples for Observational Studies.
    JAMA. 2022;327:173-174.
    

    >> Share

    
    
39. HAHN EE, Munoz-Plaza CE, Pounds D, Lyons LJ, et al
    Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2022;327:41-49.
    

    >> Share

    
    December 2021
40. OKEREKE OI, Vyas CM, Mischoulon D, Chang G, et al
    Effect of Long-term Supplementation With Marine Omega-3 Fatty Acids vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
    JAMA. 2021;326:2385-2394.
    

    >> Share

    
    November 2021
41. ABBASI J
    Closed Loop Device May Alleviate Treatment-Resistant Depression.
    JAMA. 2021;326:1785.
    

    >> Share

    
    
42. CHEN MH, Tseng PT, Liang CS
    Depressive Symptom Assessment in Medically Ill Patients.
    JAMA. 2021;326:1748.
    

    >> Share

    
    
43. HAHN SR
    Depressive Symptom Assessment in Medically Ill Patients.
    JAMA. 2021;326:1748-1749.
    

    >> Share

    
    
44. BAUMGART P, Garrick T
    Depressive Symptom Assessment in Medically Ill Patients-Reply.
    JAMA. 2021;326:1749.
    

    >> Share

    
    
45. CHRISTENSEN J, Trabjerg BB, Sun Y, Dreier JW, et al
    Association of Maternal Antidepressant Prescription During Pregnancy With Standardized Test Scores of Danish School-aged Children.
    JAMA. 2021;326:1725-1735.
    

    >> Share

    
    October 2021
46. SLOMSKI A
    Pediatric Depression and Anxiety Doubled During the Pandemic.
    JAMA. 2021;326:1246.
    

    >> Share

    
    September 2021
47. SLOMSKI A
    Novel Oral Drug Rapidly Treats Postpartum Depression.
    JAMA. 2021;326:800.
    

    >> Share

    
    August 2021
48. 
    A Simple Approach to Relieve Teens' Anxiety and Depression.
    JAMA. 2021;326:591.
    

    >> Share

    
    June 2021
49. BAUMGART P, Garrick T
    Assessment of Depressive Symptoms in Medically Ill Patients.
    JAMA. 2021;325:2497-2498.
    

    >> Share

    
    
50. LISS DT, Uchida T, Wilkes CL, Radakrishnan A, et al
    General Health Checks in Adult Primary Care: A Review.
    JAMA. 2021;325:2294-2306.
    

    >> Share

    
    May 2021
51. TOROUS J
    Digital Interventions for Adults With Symptoms of Depression and Children and Adolescents With Symptoms of Obsessive-Compulsive Disorder.
    JAMA. 2021;325:1839-1840.
    

    >> Share

    
    
52. ASPVALL K, Andersson E, Melin K, Norlin L, et al
    Effect of an Internet-Delivered Stepped-Care Program vs In-Person Cognitive Behavioral Therapy on Obsessive-Compulsive Disorder Symptoms in Children and Adolescents: A Randomized Clinical Trial.
    JAMA. 2021;325:1863-1873.
    

    >> Share

    
    
53. ARAYA R, Menezes PR, Claro HG, Brandt LR, et al
    Effect of a Digital Intervention on Depressive Symptoms in Patients With Comorbid Hypertension or Diabetes in Brazil and Peru: Two Randomized Clinical Trials.
    JAMA. 2021;325:1852-1862.
    

    >> Share

    
    April 2021
54. EL-BATTRAWY I, Behnes M, Akin I
    Depression and Incident Cardiovascular Disease.
    JAMA. 2021;325:1679-1680.
    

    >> Share

    
    
55. DAVIDSON KW, Pennells L, Di Angelantonio E
    Depression and Incident Cardiovascular Disease-Reply.
    JAMA. 2021;325:1680.
    

    >> Share

    
    
56. SLOMSKI A
    Low-Income African American Women With Hypertension and Depression.
    JAMA. 2021;325:1602.
    

    >> Share

    
    March 2021
57. BAGLEY SM
    I Am Not Burned Out.
    JAMA. 2021;325:1155-1156.
    

    >> Share

    
    
58. MORIN L, Savale L, Pham T, Colle R, et al
    Four-Month Clinical Status of a Cohort of Patients After Hospitalization for COVID-19.
    JAMA. 2021 Mar 17. pii: 2777787. doi: 10.1001/jama.2021.3331.
    

    >> Share

    
    December 2020
59. RUBIN R
    Postpartum Depression Persists Longer Than Previously Thought.
    JAMA. 2020;324:2475.
    

    >> Share

    
    
60. HARSHFIELD EL, Pennells L, Schwartz JE, Willeit P, et al
    Association Between Depressive Symptoms and Incident Cardiovascular Diseases.
    JAMA. 2020;324:2396-2405.
    

    >> Share

    
    October 2020
61. BAUM A, Wisnivesky J, Basu S, Siu AL, et al
    Association of Geographic Differences in Prevalence of Uncontrolled Chronic Conditions With Changes in Individuals' Likelihood of Uncontrolled Chronic Conditions.
    JAMA. 2020;324:1429-1438.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share